e-ISSN: Pending
Negative / Null Result ReportOpen accessTherapeutics. Pharmacology

Study and exploration of the pharmacokinetics of traditional Tibetan medicine Ruyi Zhenbao tablets after single and long-term administration

Hongping Hou; Tengfei Chen; Ziying Xu; Zihui Yu; Caixia Wang; Rongxia Liu; Bo Peng; Wei Yang · 2022 · Frontiers in Pharmacology

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Tibetan medicine is one of the oldest traditional medicine systems in the world. Taking the Ruyi Zhenbao tablet (RYZB) as an example, which is a widely used classic oral Tibetan medicine, this article discusses the pharmacokinetics of single administration and long-term treatment and analyzed its metabolic properties and tissue distribution in vivo. After single administration, blood samples were collected before administration and at different time points after administration in different groups of rats. In the study of long-term treatment effects, blood samples were collected from the animal

Abstract by Hongping Hou; Tengfei Chen; Ziying Xu; Zihui Yu; Caixia Wang; Rongxia Liu; Bo Peng; Wei Yang, Frontiers in Pharmacology (2022) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: DOAJ · DOI 10.3389/fphar.2022.948693